Cargando…
The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745417/ https://www.ncbi.nlm.nih.gov/pubmed/23977208 http://dx.doi.org/10.1371/journal.pone.0072060 |
_version_ | 1782280691513294848 |
---|---|
author | Beers, Erna Egberts, Toine C. G. Leufkens, Hubert G. M. Jansen, Paul A. F. |
author_facet | Beers, Erna Egberts, Toine C. G. Leufkens, Hubert G. M. Jansen, Paul A. F. |
author_sort | Beers, Erna |
collection | PubMed |
description | BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical industries consider necessary for rational drug prescribing to older individuals. METHODS AND FINDINGS: A 29-item-questionnaire was composed, considering the representation in trials, pharmacokinetics, efficacy, safety, and convenience of use in older individuals, with space for additions. Forty-three European professionals with an interest in medication for older individuals were included. In order to investigate their relevance, five items were included in a second questionnaire, with 11 control items. Median scores, differences between clinical and non-clinical respondents and response consistency were analysed. Consistency was present in 10 control items. Therefore, all items of the first questionnaire and the five additional items were analysed. Thirty-seven (86%) respondents returned the first questionnaire; 31/37 (84%) the second. Information about age-related differences in adverse events, locomotor effects, drug-disease interactions, dosing instructions, and information about the proportion of included 65+ patients was considered necessary by most respondents. Clinicians considered information significantly more important than the non-clinical respondents about the inclusion of 75+, time-until-benefit in older people, anticholinergic effects, drug-disease interactions, and convenience of use. Main study limitations are the focus on information for daily practice, while the ICH E7 guideline is a legislative document focused on market approval of a new medicine. Also, a questionnaire with a Likert scale has its limitations; this was addressed by providing space for comments. CONCLUSIONS: This study reveals that items considered necessary are currently not included in the ICH E7 guideline. Also, clinicians’ and non-clinicians’ opinions differed significantly in 15% of the items. Therefore, all stakeholders should collaborate to improve the availability of information for the rational prescribing to older individuals. |
format | Online Article Text |
id | pubmed-3745417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37454172013-08-23 The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription Beers, Erna Egberts, Toine C. G. Leufkens, Hubert G. M. Jansen, Paul A. F. PLoS One Research Article BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical industries consider necessary for rational drug prescribing to older individuals. METHODS AND FINDINGS: A 29-item-questionnaire was composed, considering the representation in trials, pharmacokinetics, efficacy, safety, and convenience of use in older individuals, with space for additions. Forty-three European professionals with an interest in medication for older individuals were included. In order to investigate their relevance, five items were included in a second questionnaire, with 11 control items. Median scores, differences between clinical and non-clinical respondents and response consistency were analysed. Consistency was present in 10 control items. Therefore, all items of the first questionnaire and the five additional items were analysed. Thirty-seven (86%) respondents returned the first questionnaire; 31/37 (84%) the second. Information about age-related differences in adverse events, locomotor effects, drug-disease interactions, dosing instructions, and information about the proportion of included 65+ patients was considered necessary by most respondents. Clinicians considered information significantly more important than the non-clinical respondents about the inclusion of 75+, time-until-benefit in older people, anticholinergic effects, drug-disease interactions, and convenience of use. Main study limitations are the focus on information for daily practice, while the ICH E7 guideline is a legislative document focused on market approval of a new medicine. Also, a questionnaire with a Likert scale has its limitations; this was addressed by providing space for comments. CONCLUSIONS: This study reveals that items considered necessary are currently not included in the ICH E7 guideline. Also, clinicians’ and non-clinicians’ opinions differed significantly in 15% of the items. Therefore, all stakeholders should collaborate to improve the availability of information for the rational prescribing to older individuals. Public Library of Science 2013-08-16 /pmc/articles/PMC3745417/ /pubmed/23977208 http://dx.doi.org/10.1371/journal.pone.0072060 Text en © 2013 Beers et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Beers, Erna Egberts, Toine C. G. Leufkens, Hubert G. M. Jansen, Paul A. F. The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription |
title | The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription |
title_full | The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription |
title_fullStr | The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription |
title_full_unstemmed | The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription |
title_short | The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription |
title_sort | views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescription |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745417/ https://www.ncbi.nlm.nih.gov/pubmed/23977208 http://dx.doi.org/10.1371/journal.pone.0072060 |
work_keys_str_mv | AT beerserna theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT egbertstoinecg theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT leufkenshubertgm theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT jansenpaulaf theviewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT beerserna viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT egbertstoinecg viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT leufkenshubertgm viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription AT jansenpaulaf viewsofhealthcareprofessionalsdrugdevelopersandregulatorsoninformationaboutolderpeopleneededforrationaldrugprescription |